Global Inhalation & Nasal Spray Generic Drugs Market Study 2015-2025, by Segment (Corticosteroids, Bronchodilators, Combinations), by Market (Asthma, COPDBronchodilators, Allergic Rhinitis), by Company (Teva, Sandoz (Novartis AG), Mylan)

September 2018 | 70 pages | ID: GCA506BF577EN
99Strategy

Abstracts

SNAPSHOT

Generic drugs are drugs that are not associated with any company or a brand name and are subject to regulation of countries where they are dispensed. According to US FDA, A generic drug is identical-or bioequivalent-to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies.

The global Inhalation & Nasal Spray Generic Drugs market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Corticosteroids
• Bronchodilators
• Combinations
• Decongestant Sprays
• Others

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Asthma
• COPD
• Allergic Rhinitis
• Others

Company Coverage (Sales data, Main Products & Services etc.):

• Teva
• Sandoz (Novartis AG)
• Mylan
• Allergan PLC
• Cipla
• Akorn
• Apotex
• Sun Pharma (Ranbaxy)
• Nephron Pharma
• Beximco Pharma
• Hikma (Roxane)
• XIANJU PHARMA

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Inhalation & Nasal Spray Generic Drugs Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 INHALATION & NASAL SPRAY GENERIC DRUGS MARKET BY TYPE

2.1 By Type
  2.1.1 Corticosteroids
  2.1.2 Bronchodilators
  2.1.3 Combinations
  2.1.4 Decongestant Sprays
  2.1.5 Others
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Asthma
  3.1.2 COPD
  3.1.3 Allergic Rhinitis
  3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Teva (Company Profile, Sales Data etc.)
5.2 Sandoz (Novartis AG) (Company Profile, Sales Data etc.)
5.3 Mylan (Company Profile, Sales Data etc.)
5.4 Allergan PLC (Company Profile, Sales Data etc.)
5.5 Cipla (Company Profile, Sales Data etc.)
5.6 Akorn (Company Profile, Sales Data etc.)
5.7 Apotex (Company Profile, Sales Data etc.)
5.8 Sun Pharma (Ranbaxy) (Company Profile, Sales Data etc.)
5.9 Nephron Pharma (Company Profile, Sales Data etc.)
5.10 Beximco Pharma (Company Profile, Sales Data etc.)
5.11 Hikma (Roxane) (Company Profile, Sales Data etc.)
5.12 XIANJU PHARMA (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Inhalation & Nasal Spray Generic Drugs Market 2015-2018, by Type, in USD Million
Table Global Inhalation & Nasal Spray Generic Drugs Market 2015-2018, by Type, in Volume
Table Global Inhalation & Nasal Spray Generic Drugs Market Forecast 2019-2025, by Type, in USD Million
Table Global Inhalation & Nasal Spray Generic Drugs Market Forecast 2019-2025, by Type, in Volume
Table Teva Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz (Novartis AG) Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Sandoz (Novartis AG) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan PLC Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Allergan PLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Akorn Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apotex Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharma (Ranbaxy) Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Sun Pharma (Ranbaxy) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nephron Pharma Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Nephron Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Beximco Pharma Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Beximco Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hikma (Roxane) Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of Hikma (Roxane) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table XIANJU PHARMA Overview List
Table Inhalation & Nasal Spray Generic Drugs Business Operation of XIANJU PHARMA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Inhalation & Nasal Spray Generic Drugs Market Growth 2015-2018, by Type, in USD Million
Figure Global Inhalation & Nasal Spray Generic Drugs Market Growth 2015-2018, by Type, in Volume